Regulatory

Agency Listings
Documents

AGENCY LISTINGS

Oct. 18, 2019
Your one stop reference for all healthcare associations, groups and bodies of governance.
Photo 28525486 | Background © Tatik22 | Dreamstime.com
Regulatory

FDA Advises Against Using Certain Syringes Manufactured in China Due to Quality Issues

March 21, 2024
Syringes manufactured by Jiangsu Caina Medical Co. Ltd. may have widespread issues
Photo 53713914 © Designer491 | Dreamstime.com
Regulatory

FDA Approves First Medication to Address Liver Damage in People with Nonalcoholic Fatty Liver Disease

March 15, 2024
The drug slowed the progression of the specific condition NASH in a 12-month window
Photo 187070062 © Josepalbert13 | Dreamstime.com
Regulatory

Final EPA Rule on Ethylene Oxide Emissions Standards for Sterilization Facilities

March 14, 2024
The U.S. Environmental Protection Agency announced the final rule on March 14; Premier, Inc. issues statement supporting the rule
Photo 298626063 © Mohamed Ahmed Soliman | Dreamstime.com
Regulatory

CDC Statement on the President’s Fiscal Year 2025

March 13, 2024
This budget request will enable the CDC to prioritize efforts to rapidly identify and respond to health threats; continue addressing the mental health and overdose crises; and...
Photo 198602321 | Healthcare © Nastassia Samal | Dreamstime.com
Regulatory

FDA Issues Final Decision to Withdraw Approval of Pepaxto

Feb. 26, 2024
Pepaxto (melphalan flufenamide) was approved for use in combination with dexamethasone to treat certain patients with multiple myeloma